Álvarez AK

Idioma: Español
Referencias bibliográficas: 12
Paginas: 287-292
Archivo PDF: 181.34 Kb.

RESUMEN

La incidencia de los casos de síndrome coronario agudo que se manejan en los servicios de emergencias es alta y es importante que todos los médicos tengan conocimiento básico sobre las complicaciones que esta patología puede presentar y su adecuado manejo. En este artículo se enfoca la importancia de los trastornos del ritmo cardiaco posterior a infarto al miocardio, y se revisan aspectos como su incidencia, fisiopatología, factores de riesgo y tratamiento actual.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Ashley EA, Niebauer J. Cardiology Explained. London: Remedica; 2004 ISBN-10: 1-901346-22-6

2. Avezuma; Piegas LS, Goldberg RJ; Brieger D, Stiles; MK: Paolini R; HuanG E, Gore JM; Magnitud and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes. The American Journal of Cardiology (am J Cardiol) 2008 Dec 15; vol 102 (12)pp 1577-82

3. Bacaner M; Dembo DH Arrhythmia and acute coronary syndrome suppression and cardiac resuscitation management with bretylium. American Journal of Therapeutics (am) Ther) 2009 Nov-Dec; vol 16 (6) pp 534-42

4. Benjamin M. Scirica, Eugene Braunwald, Luiz Belardinelli, Chester M. Hedgepeth, Jindrich Spinar, Whedy Wang, Jie Qin, Ewa Karwatowska-Prokopczuk, Freek W.AVerheugt and David A. Morrow. Relationship Between Nonsustained Ventricular Tachycardia After Non-STElevation Acute Coronary Syndrome and Sudden Cardiac Death Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-STElevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial Circulation 2010, 122:455-462

5. Craig M. Pratt, MD; Lemuel A. Moyé, MD, PhD The Cardiac Arrhythmia Suppression Trial Casting Suppression in a Different Light (Circulation. 1995;91:245-247.)

6. Fauci, Braunwald, Kasper et al. Harrison Principles of Internal Medicine. 17ed Copyright © 2008, by The McGraw-Hill Companies, Inc.

7. Mark Helfand, MD, MPH, Kim Peterson, MS, Vivian Christensen, PhD, Tracy Dana, MLS, and Sujata Thakurta, MPA:HA. Mark Helfand, MD, MPH, Kim Peterson, MS, Vivian Christensen, PhD, Tracy Dana, MLS, and Sujata Thakurta, MPA:HA. Drug Class Review: Beta Adrenergic Blockers Final Report Update 4 Drug Class Reviews Portland (OR): Oregon Health & Science University; July 2009.

8. N de Soyza, D Meacham, ML Murphy, JJ Kane, JE Doherty and JK Bissett Evaluation of warning arrhythmias before paroxysmal ventricular tachycardia during acute myocardial infarction in man Circulation 1979, 60:814-818 doi: 10.1161/01.CIR.60.4.814

9. Patricia Vassallo, MD Richard G. Trohman, Prescribing Amiodarone. An Evidence-Based Review of Clinical IndicationsMD JAMA, September 19, 2007—Vol 298, No. 11

10. Robert E. O’Connor, Chair; William Brady; Steven C. Brooks; Deborah Diercks; Jonathan Egan;Chris Ghaemmaghami; Venu Menon; Brian J. O’Neil; Andrew H. Travers; Demetris Yannopoulos Part 10: Acute Coronary Syndromes 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Circulation 2010 ;122;S787-S817

11. Robbins, Pratt.s, Acute Coronary Syindromes. Initial medical therapy guideline 14.2 Australian Resucitation council, February 2011

12. Yamasaki, Kazuyo Muramoto and Takayuki Sato, Motonori Ando, Rajesh G. Katare, Yoshihiko Kakinuma, Dongmei Zhang, Fumiyasu. Efferent Vagal Nerve Stimulation Protects Heart Against Ischemia-Induced Arrhythmias by Preserving Connexin43 Protein Circulation 2005, 112:164-170